Watch Ticker

Xilio Therapeutics, Inc. Common Stock

Go to Xilio Therapeutics, Inc. Common Stock Website

$0.70

0.03 (5.06%)

Live

Previous Close

$0.6663

Day Range

$0 - $0

Previous Day Range

$0.65 - $0.6779

Market Cap

$34.0 million USD

Day Vol.

Previous Day Vol.

106256

Currency

USD

Primary Exchange

Nasdaq

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Xilio Therapeutics announced the closing of a $50.0 million public offering, with the potential for up to $150.0 million in total gross proceeds if all warrants are exercised. The financing was co-led by new investors Coastlands Capital and Frazier Life Sciences, and included participation from Gilead Sciences, Logos Capital, and Samsara BioCapital.

Related tickers: XLO, GILD.

Read Full Article

Globe Newswire - Xilio Therapeutics Announces Proposed Public Offering

Xilio Therapeutics, a clinical-stage biotechnology company, announced a proposed public offering of pre-funded warrants, Series A, B, and C warrants to purchase shares of common stock. The company plans to use the net proceeds to advance the development of its product candidates and for general corporate purposes.

Related tickers: XLO.

Read Full Article

Trending Tickers

Please sign in to view